Phagos
PrivateLast Round
Series A
Oct 9, 2025
Total Funding Raised
$32.4M
Momentum Score
50 /100
Company Overview
Phagos is a biotechnology company that develops AI-driven bacteriophage therapies to combat bacterial diseases, initially focusing on animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phagos Comps
Public and private peers based on sector, stage, and business model.
Phagos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 9, 2025 | ||||
| Seed | Sep 28, 2022 |
Key People
Founding team and executive leadership
Phagos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CapHorn Invest | Series A |
| Hoxton Ventures | Series A, Seed |
| Founders Capital | Series A |
| Acurio Ventures | Series A |
| AgFunder | Seed |
| Entrepreneurs First | Series A, Seed |
| Citizen Capital | Series A |
Phagos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phagos's valuation, stock price, and market status.
